# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-25-019154
Filing Date
2025-10-24
Accepted
2025-10-23 21:34:42
Documents
19
Period of Report
2025-10-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | formdef14a.htm iXBRL | DEF 14A | 895187
2 | GRAPHIC | def14a_001.jpg | GRAPHIC | 8984
3 | GRAPHIC | annexg_001.jpg | GRAPHIC | 173466
4 | GRAPHIC | annexg_002.jpg | GRAPHIC | 283557
| Complete submission text file | 0001493152-25-019154.txt |  | 2635523

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | scnx-20241231.xsd | EX-101.SCH | 4403
6 | XBRL DEFINITION FILE | scnx-20241231_def.xml | EX-101.DEF | 7955
7 | XBRL LABEL FILE | scnx-20241231_lab.xml | EX-101.LAB | 57644
8 | XBRL PRESENTATION FILE | scnx-20241231_pre.xml | EX-101.PRE | 40934
21 | EXTRACTED XBRL INSTANCE DOCUMENT | formdef14a_htm.xml | XML | 60290

Mailing Address 20 AUSTIN BLVD. COMMACK NY 11725
Business Address 20 AUSTIN BLVD. COMMACK NY 11725 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39199 | Film No.: 251414162
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)